MT-5625 high dose: Clinical Trials

1 trial of MT-5625 high dose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow MT-5625 high dose: new trials by email Literature Review of MT-5625 high dose trials Research Report on MT-5625 high dose

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants
MT-5625 low dose, MT-5625 middle dose, MT-5625 high dose - Healthy
Phase 1CompletedTanabe Pharma Corporation1102018-07-032019-08-06

Sponsors

Tanabe Pharma Corporation (1)

Countries

Australia (1)  ·  South Africa (1)

Results publications

PMID 34454786